Filing Flows › Firefly Neuroscience (AIFF) › Q2 2026 › vs Q1 2026
Firefly Neuroscience (AIFF) Q2 2026 vs Q1 2026 (quarter over quarter)
Firefly Neuroscience's revenue rose $29K (+6%) from $485K in Q1 2026 to $514K in Q2 2026. The biggest changes: Subscription and Circulation +$82K (+51%); Service −$52K (-24%); Rentals −$10K (-67%).
Firefly Neuroscience, Q2 2026: revenue $514K (+72% year over year), operating margin -384.0%, net loss $2.0M, operating cash flow −$1.8M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Subscription and Circulation | $243K | $161K | $82K | +51% |
| Service | $164K | $216K | −$52K | -24% |
| Product | $92K | $87K | $5K | +6% |
| Product and Service, Other | $10K | $6K | $4K | +67% |
| Rentals | $5K | $15K | −$10K | -67% |
| Revenue | $514K | $485K | $29K | +6% |
| Net loss | $2.0M | $2.0M | −$20K | -1% |
| Costs & expenses | $2.5M | $2.5M | $3K | +0.1% |
| Operating costs | $2.5M | $2.5M | −$7K | -0.3% |
| Interest & other, net | $10K | −$6K | $16K | — |
| Cost of revenue | $261K | $264K | −$3K | -1% |
| Research & development | $525K | $424K | $101K | +24% |
| Sales & marketing | $180K | $141K | $39K | +28% |
| General & admin | $1.5M | $1.7M | −$144K | -9% |
| Operating cash sources | $2.1M | $2.4M | −$351K | -15% |
| Depreciation & amortization | $47K | $45K | $2K | +4% |
| Share-based compensation | $268K | $423K | −$155K | -37% |
| Cash used in operations | $1.8M | $1.9M | −$198K | -10% |
| Net loss absorbed | $2.0M | $2.0M | −$20K | -1% |
| Working capital & other | $81K | $412K | −$331K | -80% |
Questions
How much did Firefly Neuroscience's revenue grow quarter over quarter in Q2 2026?
Firefly Neuroscience's revenue rose $29K (+6%) from $485K in Q1 2026 to $514K in Q2 2026.
What drove Firefly Neuroscience's revenue change in Q2 2026?
Subscription and Circulation +$82K (+51%); Service −$52K (-24%); Rentals −$10K (-67%).